Wegovy

• Ozempic maker says unapproved compounded drugs being sold in Canada

  Novo Nordisk says it has filed a complaint with Health Canada regarding the promotion and sale of compounded semaglutide – a key ingredient in both Ozempic and Wegovy.

  Health

  Jul 30
  
• Ozempic, Wegovy use may be linked to ‘eye stroke’ and blindness, study finds

  The use of semaglutide drugs, like Wegovy and Ozempic, may have an increased risk of sudden and irreversible vision loss and blindness, the study found.

  Health

  Jul 4
  
• Advertisement
• Are ‘Ozempic babies’ on the rise? What to know about the growing phenomenon

  The term 'Ozempic babies' is taking social media by storm as a growing number of women have shared their stories of getting pregnant after using the popular weight-loss drug.

  Health

  Jun 1
• Advertisement
• Nestle to target American Ozempic, Wegovy users with US$5 pizzas

  Nestle will market a new, US$5 line of frozen pizzas and protein-enriched pastas in the U.S., which it says it designed specifically for people taking Wegovy or Ozempic.

  Consumer

  May 21
• Wegovy now in Canada: Who should (and shouldn’t) use the weight-loss drug

  After years of persistent shortages, Canadians can now access Wegovy, an on-label weight loss medication, made by the same manufacturers of Ozempic.

  Health

  May 6
• Wegovy set to launch in Canada. What to know about the weight-loss drug

  Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.

  Health

  May 2
• EU probe of Ozempic, Wegovy ends with no evidence of link to suicide

  The European Medicines Agency regulatory committee announced the results of its review on Friday, the latest group to find no known tie between drugs like Ozempic and suicide.

  Health

  Apr 12
• Wegovy will be available for Canadians in spring 2024, company says

  Canadians will be able to get their hands on Wegovy, a weight-loss drug from Ozempic-maker Novo Nordisk, in spring 2024, the company said Monday.

  Health

  Feb 5
• Advertisement
• Ozempic maker says its Wegovy drug can cut risk of serious heart problems

  Ozempic maker Novo Nordisk says the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone

  Health

  Nov 13, 2023
• Advertisement
• Ozempic linked to stomach paralysis, other gastrointestinal issues: UBC study

  The study, published in JAMA, found these adverse gastrointestinal effects happen in non-diabetic patients using the drugs specifically for weight loss.

  Canada

  Oct 5, 2023